Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000289200 | SCV000429936 | uncertain significance | Neuroblastoma Susceptibility | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000418057 | SCV000531451 | likely benign | not specified | 2016-09-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001000138 | SCV001156606 | likely benign | Neuroblastoma, susceptibility to, 3 | 2019-03-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001000138 | SCV002394130 | likely benign | Neuroblastoma, susceptibility to, 3 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257646 | SCV002528465 | benign | Hereditary cancer-predisposing syndrome | 2021-03-31 | criteria provided, single submitter | curation |